Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 24
SponsorUniversity Hospital, Brest

About this trial

Pain is described by patients with a Neurodevelopmental Disorder (NDD), including Autism Spectrum Disorder (ASD), Intellectual Development Disorder (IDD) or multiple disabilities, and the family as one of the main associated disorders; its management is also one of the main concerns of families and professionals. At present, there is no validated and tested pain management system in populations facing complex pain situations. In response to the lack of a pain management services, a multi-disciplinary mobile team was set up in September 2022 at the Brest University Hospital (Mobile Pain Handicap Team Intellectual Disability 0-25 years; MoDIDol). This team offers a specific protocol for the assessment and management of pain that takes into account the social and family environment, the living context and the clinical characteristics of patients (children, adolescents and young adults (0-25 years) with IDD, ASD or multiple disabilities). The team includes at least one paediatrician specialising in the assessment and treatment of pain and a nurse, and travels to patients' usual living environments.

Eligibility criteria

Qualifiers

Aged from birth up to 24 years inclusive (i.e., under 25 years old)

Medical diagnosis of intellectual disability (ID), isolated or associated with autism spectrum disorder (ASD), developmental disorder (DD), or profound multiple disabilities, based on international classification systems (ICD-11 or DSM-5)

Confirmed probable or definite pain diagnosis, as validated by the MoDIDol team

PGIC score ≥ 3

Disqualifiers

More than three places of residence and/or care settings

Parents or legal guardians who do not have sufficient language or comprehension skills to provide informed consent or complete study questionnaires

Trial design

Treatments tested in this trial

  • MoDIDol intervention

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Brest

Lead sponsor

Fondation de France

Collaborator

Université de Bretagne Occidentale, Brest-France

Collaborator

Fondation Perce Neige

Collaborator